Literature DB >> 19696299

Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition.

Sanaz A Jansen1, Akiko Shimauchi, Lindsay Zak, Xiaobing Fan, Abbie M Wood, Gregory S Karczmar, Gillian M Newstead.   

Abstract

OBJECTIVE: The purpose of this study was to compare MRI kinetic curve data acquired with three systems in the evaluation of malignant lesions of the breast.
MATERIALS AND METHODS: The cases of 601 patients with 682 breast lesions (185 benign, 497 malignant) were selected for review. The malignant lesions were classified as ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC), and other. The dynamic MRI protocol consisted of one unenhanced and three to seven contrast-enhanced images acquired with one of three imaging protocols and systems. An experienced radiologist analyzed the shapes of the kinetic curves according to the BI-RADS lexicon. Several quantitative kinetic parameters were calculated, and the kinetic parameters of malignant lesions were compared across the three systems.
RESULTS: Imaging protocol and system 1 were used to image 304 malignant lesions (185 IDC, 62 DCIS); imaging protocol and system 2, 107 lesions (72 IDC, 21 DCIS); and imaging protocol and system 3, 86 lesions (64 IDC, 17 DCIS). Compared with those visualized with imaging protocols and systems 1 and 2, IDC lesions visualized with imaging protocol and system 3 had significantly less initial enhancement, longer time to peak enhancement, and a slower washout rate (p < 0.004). Only 47% of IDC lesions imaged with imaging protocol and system 3 exhibited washout type curves, compared with 75% and 74% of those imaged with imaging protocols and systems 2 and 1, respectively. The diagnostic accuracy of kinetic analysis was lowest for imaging protocol and system 3, but the difference was not statistically significant.
CONCLUSION: The kinetic curve data on malignant lesions acquired with one system showed significantly lower initial contrast uptake and a different curve shape in comparison with data acquired with the other two systems. Differences in k-space sampling, T1 weighting, and magnetization transfer effects may be explanations for the difference.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696299      PMCID: PMC2938789          DOI: 10.2214/AJR.08.2025

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  29 in total

Review 1.  Dynamic image interpretation of MRI of the breast.

Authors:  C K Kuhl; H H Schild
Journal:  J Magn Reson Imaging       Date:  2000-12       Impact factor: 4.813

2.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?

Authors:  C K Kuhl; P Mielcareck; S Klaschik; C Leutner; E Wardelmann; J Gieseke; H H Schild
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

3.  DCEMRI of breast lesions: is kinetic analysis equally effective for both mass and nonmass-like enhancement?

Authors:  Sanaz A Jansen; Xiaobing Fan; Gregory S Karczmar; Hiroyuki Abe; Robert A Schmidt; Maryellen Giger; Gillian M Newstead
Journal:  Med Phys       Date:  2008-07       Impact factor: 4.071

4.  In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging.

Authors:  P Viehweg; D Lampe; J Buchmann; S H Heywang-Köbrunner
Journal:  MAGMA       Date:  2000-12       Impact factor: 2.310

Review 5.  MR imaging in the management of patients with breast cancer.

Authors:  Gillian Maclaine Newstead
Journal:  Semin Ultrasound CT MR       Date:  2006-08       Impact factor: 1.875

Review 6.  MR imaging of the breast.

Authors:  S G Orel
Journal:  Radiol Clin North Am       Date:  2000-07       Impact factor: 2.303

7.  Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor Histopathology and Angiogenesis in Breast Carcinoma.

Authors:  Laura Esserman; Nola Hylton; Tracy George; Noel Weidner
Journal:  Breast J       Date:  1999-01       Impact factor: 2.431

8.  The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease.

Authors:  S W Duffy; L Tabar; B Vitak; N E Day; R A Smith; H H T Chen; M F A Yen
Journal:  Eur J Cancer       Date:  2003-08       Impact factor: 9.162

Review 9.  Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer.

Authors:  Nehmat Houssami; Stefano Ciatto; Petra Macaskill; Sarah J Lord; Ruth M Warren; J Michael Dixon; Les Irwig
Journal:  J Clin Oncol       Date:  2008-05-12       Impact factor: 44.544

10.  Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI.

Authors:  J Veltman; R Mann; T Kok; I M Obdeijn; N Hoogerbrugge; J G Blickman; C Boetes
Journal:  Eur Radiol       Date:  2008-02-13       Impact factor: 5.315

View more
  31 in total

1.  Development and characterization of a dynamic lesion phantom for the quantitative evaluation of dynamic contrast-enhanced MRI.

Authors:  Melanie Freed; Jacco A de Zwart; Prasanna Hariharan; Matthew R Myers; Aldo Badano
Journal:  Med Phys       Date:  2011-10       Impact factor: 4.071

2.  A feasible high spatiotemporal resolution breast DCE-MRI protocol for clinical settings.

Authors:  Luminita A Tudorica; Karen Y Oh; Nicole Roy; Mark D Kettler; Yiyi Chen; Stephanie L Hemmingson; Aneela Afzal; John W Grinstead; Gerhard Laub; Xin Li; Wei Huang
Journal:  Magn Reson Imaging       Date:  2012-07-06       Impact factor: 2.546

3.  Evaluation of Kinetic Entropy of Breast Masses Initially Found on MRI using Whole-lesion Curve Distribution Data: Comparison with the Standard Kinetic Analysis.

Authors:  Akiko Shimauchi; Hiroyuki Abe; David V Schacht; Jian Yulei; Federico D Pineda; Sanaz A Jansen; Rajiv Ganesh; Gillian M Newstead
Journal:  Eur Radiol       Date:  2015-02-20       Impact factor: 5.315

4.  Computerized assessment of breast lesion malignancy using DCE-MRI robustness study on two independent clinical datasets from two manufacturers.

Authors:  Weijie Chen; Maryellen L Giger; Gillian M Newstead; Ulrich Bick; Sanaz A Jansen; Hui Li; Li Lan
Journal:  Acad Radiol       Date:  2010-07       Impact factor: 3.173

5.  Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging.

Authors:  Wei Huang; Luminita A Tudorica; Xin Li; Sunitha B Thakur; Yiyi Chen; Elizabeth A Morris; Ian J Tagge; Maayan E Korenblit; William D Rooney; Jason A Koutcher; Charles S Springer
Journal:  Radiology       Date:  2011-08-09       Impact factor: 11.105

6.  Can signal enhancement ratio (SER) reduce the number of recommended biopsies without affecting cancer yield in occult MRI-detected lesions?

Authors:  Vignesh A Arasu; Ryan C-Y Chen; David N Newitt; C Belinda Chang; Hilda Tso; Nola M Hylton; Bonnie N Joe
Journal:  Acad Radiol       Date:  2011-03-21       Impact factor: 3.173

7.  Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions.

Authors:  Savannah C Partridge; Karen M Stone; Roberta M Strigel; Wendy B DeMartini; Sue Peacock; Constance D Lehman
Journal:  Acad Radiol       Date:  2014-07-04       Impact factor: 3.173

8.  Dynamic contrast-enhanced and diffusion-weighted MR imaging in the characterisation of small, non-palpable solid testicular tumours.

Authors:  Lucia Manganaro; Matteo Saldari; Carlotta Pozza; Valeria Vinci; Daniele Gianfrilli; Ermanno Greco; Giorgio Franco; Maria Eleonora Sergi; Michele Scialpi; Carlo Catalano; Andrea M Isidori
Journal:  Eur Radiol       Date:  2017-08-30       Impact factor: 5.315

9.  A prospective study of the utility of magnetic resonance imaging in determining candidacy for partial breast irradiation.

Authors:  Paige L Dorn; Hania A Al-Hallaq; Farah Haq; Mira Goldberg; Hiroyuki Abe; Yasmin Hasan; Steven J Chmura
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-07-24       Impact factor: 7.038

10.  Intraindividual, randomized comparison of the macrocyclic contrast agents gadobutrol and gadoterate meglumine in breast magnetic resonance imaging.

Authors:  Eva M Fallenberg; Diane M Renz; Bettina Karle; Carsten Schwenke; Barbara Ingod-Heppner; Angela Reles; Florian J Engelken; Alexander Huppertz; Bernd Hamm; Matthias Taupitz
Journal:  Eur Radiol       Date:  2014-09-25       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.